AZD6765 (lanicemine)

lanicemine · AstraZeneca

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AZD6765 (lanicemine), covering 2017-04-11 to 2017-04-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder [Phase 2]